{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:02:12Z","timestamp":1789628532120,"version":"build-2803163510"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s10620-026-10161-y","type":"journal-article","created":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T22:33:44Z","timestamp":1786314824000},"page":"6053-6063","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Age on Inflammatory Bowel Disease Presentation and Management in Older Adults"],"prefix":"10.1007","volume":"71","author":[{"given":"Christina","family":"Sisliyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome Tomas","family":"Andres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian","family":"Keyashian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,9]]},"reference":[{"key":"10161_CR1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1053\/j.gastro.2020.08.060","volume":"160","author":"Ashwin N Ananthakrishnan","year":"2021","unstructured":"Ananthakrishnan Ashwin N, Nguyen Geoffrey C, Bernstein Charles N. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Patients: Expert Review. Gastroenterology 2021;160:445\u2013451. https:\/\/doi.org\/10.1053\/j.gastro.2020.08.060.","journal-title":"Gastroenterology"},{"key":"10161_CR2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S2468-1253(22)00358-2","volume":"8","author":"S Singh","year":"2023","unstructured":"Singh S, Boland BS, Jess T, Moore AA. Management of inflammatory bowel diseases in older adults. Lancet Gastroenterol Hepatol. 2023;8:368\u2013382. https:\/\/doi.org\/10.1016\/S2468-1253(22)00358-2.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"10161_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0720-048X(00)00238-2","volume":"35","author":"Kinga Karlinger","year":"2000","unstructured":"Karlinger Kinga, Gy\u00f6rke Tam\u00e1s, Mak\u00f6 Ern\u0151, Mester \u00c1d\u00e1m, Tarj\u00e1n Zsolt. The epidemiology and the pathogenesis of inflammatory bowel disease. European Journal of Radiology 2000;35:154\u2013167. https:\/\/doi.org\/10.1016\/S0720-048X(00)00238-2.","journal-title":"European Journal of Radiology"},{"key":"10161_CR4","doi-asserted-by":"publisher","first-page":"e356","DOI":"10.1016\/S2666-7568(22)00060-5","volume":"3","author":"S Vieujean","year":"2022","unstructured":"Vieujean S, Caron B, Jairath V et al. Is it time to include older adults in inflammatory bowel disease trials? A call for action. Lancet Healthy Longev. 2022;3:e356\u2013e366. https:\/\/doi.org\/10.1016\/S2666-7568(22)00060-5.","journal-title":"Lancet Healthy Longev."},{"key":"10161_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.maturitas.2018.01.015","volume":"110","author":"M Butter","year":"2018","unstructured":"Butter M, Weiler S, Biedermann L et al. Clinical manifestations, pathophysiology, treatment and outcome of inflammatory bowel diseases in older people. Maturitas. 2018;110:71\u201378. https:\/\/doi.org\/10.1016\/j.maturitas.2018.01.015.","journal-title":"Maturitas."},{"key":"10161_CR6","doi-asserted-by":"publisher","first-page":"175628482110233","DOI":"10.1177\/17562848211023399","volume":"3","author":"SJ Hong","year":"2021","unstructured":"Hong SJ, Katz S. The elderly IBD patient in the modern era: changing paradigms in risk stratification and therapeutic management. Therap Adv Gastroenterol. 2021;3:17562848211023400. https:\/\/doi.org\/10.1177\/17562848211023399.","journal-title":"Therap Adv Gastroenterol."},{"key":"10161_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/2050640619860661","volume":"8","author":"L Cantoro","year":"2020","unstructured":"Cantoro L, Lenti MV, Monterubbianesi R, Cicala M et al. Early-onset versus late-onset Crohn\u2019s disease: An Italian cohort study. United European Gastroenterol J. 2020;8:52\u201358. https:\/\/doi.org\/10.1177\/2050640619860661.","journal-title":"United European Gastroenterol J."},{"key":"10161_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/gutjnl-2012-303864","volume":"63","author":"C Charpentier","year":"2014","unstructured":"Charpentier C, Salleron J, Savoye G et al. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut. 2014;63:423\u2013432. https:\/\/doi.org\/10.1136\/gutjnl-2012-303864.","journal-title":"Gut."},{"key":"10161_CR9","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1097\/MIB.0000000000001115","volume":"23","author":"B Kochar","year":"2017","unstructured":"Kochar B, Long MD, Galanko J et al. Inflammatory Bowel Disease is Similar in Patients with Older Onset and Younger Onset. Inflamm Bowel Dis. 2017;23:1187\u20131194. https:\/\/doi.org\/10.1097\/MIB.0000000000001115.","journal-title":"Inflamm Bowel Dis."},{"key":"10161_CR10","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1016\/j.cgh.2020.02.048","volume":"18","author":"JJ Rozich","year":"2020","unstructured":"Rozich JJ, Dulai PS, Fumery M, Sandborn WJ, Singh S. Progression of elderly onset inflammatory bowel diseases: a systematic review and meta-analysis of population-based cohort studies. Clinical gastroenterology and hepatology 2020;18:2437\u20132447.","journal-title":"Clinical gastroenterology and hepatology"},{"key":"10161_CR11","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S0399-8320(04)95216-5","volume":"28","author":"I Etienney","year":"2004","unstructured":"Etienney I, Bouhnik Y, Gendre JP et al. Crohn\u2019s disease over 20 years after diagnosis in a referral population. Gastroenterologie clinique et biologique 2004;28:1233\u20131239.","journal-title":"Gastroenterologie clinique et biologique"},{"key":"10161_CR12","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.cgh.2024.08.011","volume":"23","author":"S Singh","year":"2025","unstructured":"Singh S, Poulsen GJ, Bisgaard TH, Bonfils L, Jess T. Epidemiology of Elderly Onset IBD: A Nationwide Population-Based Cohort Study. Clin Gastroenterol Hepatol. 2025;23:1204-1215.e11. https:\/\/doi.org\/10.1016\/j.cgh.2024.08.011.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10161_CR13","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1097\/MIB.0000000000000732","volume":"22","author":"Abdo M Saad","year":"2016","unstructured":"Saad Abdo M, Czul Frank, Sakuraba Atsushi, Rubin David T, Cohen Russell D. Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn\u2019s Disease. Inflammatory Bowel Diseases 2016;22:1027\u20131031. https:\/\/doi.org\/10.1097\/MIB.0000000000000732.","journal-title":"Inflammatory Bowel Diseases"},{"key":"10161_CR14","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1097\/MIB.0000000000000849","volume":"22","author":"Jason K Hou","year":"2016","unstructured":"Hou Jason K, Feagins Linda A, Waljee Akbar K. Characteristics and Behavior of Elderly-onset Inflammatory Bowel Disease: A Multi-center US Study. Inflammatory Bowel Diseases 2016;22:2200\u20132205. https:\/\/doi.org\/10.1097\/MIB.0000000000000849.","journal-title":"Inflammatory Bowel Diseases"},{"key":"10161_CR15","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/ajg.2016.304","volume":"111","author":"H Cheddani","year":"2016","unstructured":"Cheddani H, Dauchet L, Fumery M et al. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study. Am J Gastroenterol. 2016;111:1428\u20131436. https:\/\/doi.org\/10.1038\/ajg.2016.304.","journal-title":"Am J Gastroenterol."},{"key":"10161_CR16","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/archinte.146.4.753","volume":"146","author":"PC Harper","year":"1986","unstructured":"Harper PC, McAuliffe TL, Beeken WL. Crohn\u2019s disease in the elderly. A statistical comparison with younger patients matched for sex and duration of disease. Arch Intern Med. 1986;146:753\u2013755. https:\/\/doi.org\/10.1001\/archinte.146.4.753.","journal-title":"Arch Intern Med."},{"key":"10161_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/j.gastro.2017.10.034","volume":"154","author":"\u00c5H Everhov","year":"2018","unstructured":"Everhov \u00c5H, Halfvarson J, Myrelid P et al. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden. Gastroenterology. 2018;154:518-528.e15. https:\/\/doi.org\/10.1053\/j.gastro.2017.10.034.","journal-title":"Gastroenterology."},{"key":"10161_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/apt.18106","volume":"60","author":"RLM Nordestgaard","year":"2024","unstructured":"Nordestgaard RLM, Wewer MD, Malham M et al. Treatment of inflammatory bowel disease with steroid-sparing medications is age-dependent\u2013Results from a Danish nationwide cohort study, 2000\u20132018. Aliment Pharmacol Ther. 2024;60:457\u2013468. https:\/\/doi.org\/10.1111\/apt.18106.","journal-title":"Aliment Pharmacol Ther."},{"key":"10161_CR19","doi-asserted-by":"publisher","unstructured":"Waljee AK, Wiitala WL, Govani S et al. Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort. PLoS One. 2016 23;11: e0158017. https:\/\/doi.org\/10.1371\/journal.pone.0158017. Erratum in: PLoS One. 2018 9;13: e0197341. 10.1371\/journal.pone.0197341","DOI":"10.1371\/journal.pone.0158017"},{"key":"10161_CR20","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/apt.14334","volume":"46","author":"CP Selinger","year":"2017","unstructured":"Selinger CP, Parkes GC, Bassi A et al. A multi-centre audit of excess steroid use in 1176 patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2017;46:964\u2013973. https:\/\/doi.org\/10.1111\/apt.14334.","journal-title":"Aliment Pharmacol Ther."},{"key":"10161_CR21","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/jgh3.12841","volume":"6","author":"KL Farraj","year":"2022","unstructured":"Farraj KL, Pellegrini JR, Munshi RF et al. Chronic steroid use: An overlooked impact on patients with inflammatory bowel disease. JGH Open 2022;6:910\u2013914. https:\/\/doi.org\/10.1002\/jgh3.12841.","journal-title":"JGH Open"},{"key":"10161_CR22","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1097\/MIB.0000000000000747","volume":"22","author":"Matthew Geisz","year":"2016","unstructured":"Geisz Matthew, Ha Christina, Kappelman Michael D et al. Medication Utilization and the Impact of Continued Corticosteroid Use on Patient-reported Outcomes in Older Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016;22:1435\u20131441. https:\/\/doi.org\/10.1097\/MIB.0000000000000747.","journal-title":"Inflammatory Bowel Diseases"},{"key":"10161_CR23","first-page":"461","volume":"92","author":"GA Akerkar","year":"1997","unstructured":"Akerkar GA, Peppercorn MA, Hamel MB, Parker RA. Corticosteroid-associated complications in elderly Crohn\u2019s disease patients. Am J Gastroenterol. 1997;92:461\u2013464.","journal-title":"Am J Gastroenterol."},{"key":"10161_CR24","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1097\/MIB.0000000000000817","volume":"22","author":"Shail M Govani","year":"2016","unstructured":"Govani Shail M, Wiitala Wyndy L, Stidham Ryan W et al. Age Disparities in the Use of Steroid-sparing Therapy for Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016;22:1923\u20131928. https:\/\/doi.org\/10.1097\/MIB.0000000000000817.","journal-title":"Inflammatory Bowel Diseases"},{"key":"10161_CR25","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1093\/ibd\/izy389","volume":"25","author":"VC Kariyawasam","year":"2019","unstructured":"Kariyawasam VC, Kim S, Mourad FH et al. Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel Disease. Inflamm Bowel Dis. 2019;25:1390\u20131398. https:\/\/doi.org\/10.1093\/ibd\/izy389.","journal-title":"Inflamm Bowel Dis."},{"key":"10161_CR26","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/apt.15458","volume":"50","author":"M Calafat","year":"2019","unstructured":"Calafat M, Ma\u00f1osa M, Ca\u00f1ete F et al. Increased risk of thiopurine-related adverse events in elderly patients with IBD. Aliment Pharmacol Ther. 2019;50:780\u2013788. https:\/\/doi.org\/10.1111\/apt.15458.","journal-title":"Aliment Pharmacol Ther."},{"key":"10161_CR27","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00535-012-0686-9","volume":"48","author":"M Naganuma","year":"2013","unstructured":"Naganuma M, Kunisaki R, Yoshimura N, Takeuchi Y, Watanabe M. A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease. J Gastroenterol. 2013;48:595\u2013600. https:\/\/doi.org\/10.1007\/s00535-012-0686-9.","journal-title":"J Gastroenterol."},{"key":"10161_CR28","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1080\/00365521.2018.1501603","volume":"53","author":"JM Huguet","year":"2018","unstructured":"Huguet JM, Iborra M, Bosca-Watts MM et al. Inflammatory bowel disease in patients over the age of 70 y. Does the disease duration influence its behavior? Scandinavian Journal of Gastroenterology 2018;53:1079\u20131084. https:\/\/doi.org\/10.1080\/00365521.2018.1501603.","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10161_CR29","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/MEG.0000000000000350","volume":"27","author":"T Schr\u00f6der","year":"2015","unstructured":"Schr\u00f6der T, Schmidt KJ, Olsen V et al. Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment. Eur J Gastroenterol Hepatol. 2015;27:698\u2013704. https:\/\/doi.org\/10.1097\/MEG.0000000000000350.","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10161_CR30","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/MIB.0000000000001031","volume":"23","author":"C Alexakis","year":"2017","unstructured":"Alexakis C, Saxena S, Chhaya V et al. Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study. Inflamm. Bowel Dis. 2017;23:672\u2013680. https:\/\/doi.org\/10.1097\/MIB.0000000000001031.","journal-title":"Inflamm. Bowel Dis."},{"key":"10161_CR31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/jgh.13169","volume":"31","author":"B Kim","year":"2016","unstructured":"Kim B, Cheon JH, Moon HJ et al. Crohn\u2019s disease prognosis and early immunomodulator therapy: Results from the CONNECT study. J Gastroenterol Hepatol. 2016;31:126\u2013132. https:\/\/doi.org\/10.1111\/jgh.13169.","journal-title":"J Gastroenterol Hepatol."},{"key":"10161_CR32","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1136\/jim-2022-002486","volume":"70","author":"F Xu","year":"2022","unstructured":"Xu F, Liu Y, Greenlund K, Carlson S. Trends and demographic patterns in biologic and corticosteroid prescriptions for inflammatory bowel disease: findings from electronic medical records, 2011\u20132020. J Investig Med. 2022;70:1771\u20131776. https:\/\/doi.org\/10.1136\/jim-2022-002486.","journal-title":"J Investig Med."},{"key":"10161_CR33","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/MEG.0000000000001047","volume":"30","author":"P Holko","year":"2018","unstructured":"Holko P, Kawalec P, Stawowczyk E. Prevalence and drug treatment practices of inflammatory bowel diseases in Poland in the years 2012\u20132014: an analysis of nationwide databases. Eur J Gastroenterol Hepatol. 2018;30:456\u2013464. https:\/\/doi.org\/10.1097\/MEG.0000000000001047.","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10161_CR34","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1007\/s12325-024-02840-x","volume":"41","author":"M Dovizio","year":"2024","unstructured":"Dovizio M, Hartz S, Buzzoni C et al. Real-World Treatment Patterns and Healthcare Resource Use for Ulcerative Colitis and Crohn\u2019s Disease in Italy. Adv Ther. 2024;41:2282\u20132298. https:\/\/doi.org\/10.1007\/s12325-024-02840-x.","journal-title":"Adv Ther."},{"key":"10161_CR35","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1111\/ans.18713","volume":"93","author":"HL Giddings","year":"2023","unstructured":"Giddings HL, Ng K-S, Solomon MJ et al. Reducing rate of total colectomies for ulcerative colitis but higher morbidity in the biologic era: an 18-year linked data study from New South Wales Australia. ANZ Journal of Surgery 2023;93:2928\u20132938. https:\/\/doi.org\/10.1111\/ans.18713.","journal-title":"ANZ Journal of Surgery"},{"key":"10161_CR36","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/jgh3.12229","volume":"4","author":"R Rajan","year":"2020","unstructured":"Rajan R, Trinder MW, Lo J, Theophilus M. Assessing the efficacy of TNF-alpha inhibitors in preventing emergency and emergent colectomies. JGH Open 2020;4:140\u2013144. https:\/\/doi.org\/10.1002\/jgh3.12229.","journal-title":"JGH Open"},{"key":"10161_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/jcm13020365","volume":"13","author":"T Holvoet","year":"2024","unstructured":"Holvoet T, Truyens M, De Galan C et al. Safety and Effectiveness of Vedolizumab and Ustekinumab in Elderly Patients with Inflammatory Bowel Disease: A Real-Life Multicentric Cohort Study. J Clin Med. 2024;13:365. https:\/\/doi.org\/10.3390\/jcm13020365.","journal-title":"J Clin Med."},{"key":"10161_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-025-09395-z","author":"M Sachar","year":"2025","unstructured":"Sachar M, Rojanasopondist P, Beaty W et al. Safety and Efficacy of Ustekinumab and Vedolizumab Among Older Adults with Inflammatory Bowel Disease. Dig Dis Sci. 2025. https:\/\/doi.org\/10.1007\/s10620-025-09395-z.","journal-title":"Dig Dis Sci."},{"key":"10161_CR39","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1007\/s12325-023-02605-y","volume":"40","author":"A Afzali","year":"2023","unstructured":"Afzali A, Lukanova R, Hennessy F et al. Unmet Needs in Real-World Advanced Therapy-Na\u00efve and -Experienced Patients with Moderately to Severely Active Ulcerative Colitis in the United States. Adv Ther. 2023;40:4321\u20134338. https:\/\/doi.org\/10.1007\/s12325-023-02605-y.","journal-title":"Adv Ther."},{"key":"10161_CR40","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1007\/s10620-021-07117-9","volume":"67","author":"R Garg","year":"2022","unstructured":"Garg R, Aggarwal M, Butler R et al. Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn\u2019s Disease Patients. Dig Dis Sci. 2022;67:3138\u20133147. https:\/\/doi.org\/10.1007\/s10620-021-07117-9.","journal-title":"Dig Dis Sci."},{"key":"10161_CR41","doi-asserted-by":"publisher","first-page":"170","DOI":"10.20524\/aog.2020.0447","volume":"33","author":"H Ibraheim","year":"2020","unstructured":"Ibraheim H, Samaan MA, Srinivasan A et al. Effectiveness and safety of vedolizumab in inflammatory bowel disease patients aged 60 and over: an observational multicenter UK experience. Ann Gastroenterol. 2020;33:170\u2013177. https:\/\/doi.org\/10.20524\/aog.2020.0447.","journal-title":"Ann Gastroenterol."},{"key":"10161_CR42","doi-asserted-by":"publisher","first-page":"i675","DOI":"10.1093\/ecco-jcc\/jjac190.0678","volume":"17","author":"R Atreya","year":"2023","unstructured":"Atreya R, Irving P, Fujiya M et al. P548 Efficacy outcomes of placebo maintenance treatment in patients with moderate to severe Crohn\u2019s disease who responded to placebo induction therapy: Post-hoc analysis of the Phase 3 ADVANCE. MOTIVATE, and FORTIFY Risankizumab Studies, Journal of Crohn\u2019s and Colitis 2023;17:i675\u2013i677. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjac190.0678.","journal-title":"MOTIVATE, and FORTIFY Risankizumab Studies, Journal of Crohn\u2019s and Colitis"},{"key":"10161_CR43","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/ecco-jcc\/jjab213","volume":"16","author":"M Calafat","year":"2022","unstructured":"Calafat M, Ma\u00f1osa M, Ricart E, ENEIDA Study Group of GETECCU et al. Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry. J Crohns Colitis. 2022;16:946\u2013953. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab213.","journal-title":"J Crohns Colitis."},{"key":"10161_CR44","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1097\/MCG.0000000000001458","volume":"56","author":"J Schwartz","year":"2022","unstructured":"Schwartz J, Stein DJ, Lipcsey M, Li B, Feuerstein JD. High Rates of Mortality in Geriatric Patients Admitted for Inflammatory Bowel Disease Management. J Clin Gastroenterol. 2022;56:e20\u2013e26. https:\/\/doi.org\/10.1097\/MCG.0000000000001458.","journal-title":"J Clin Gastroenterol."},{"key":"10161_CR45","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1093\/ibd\/izae184","volume":"31","author":"S Aziz","year":"2025","unstructured":"Aziz S, Akhlaq A, Owings A et al. Mortality Trends in Inflammatory Bowel Disease by Age, Sex, and Race in the United States from 1999 to 2020. Inflamm Bowel Dis. 2025;31:1574\u20131582. https:\/\/doi.org\/10.1093\/ibd\/izae184.","journal-title":"Inflamm Bowel Dis."},{"key":"10161_CR46","doi-asserted-by":"publisher","unstructured":"Noor NM, Lee JC, Bond S et al; PROFILE Study Group. A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn\u2019s disease (PROFILE): a multicentre, open-label randomised controlled trial. Lancet Gastroenterol Hepatol. 2024; 9: 415\u2013427. https:\/\/doi.org\/10.1016\/S2468-1253(24)00034-7. Erratum in: Lancet Gastroenterol Hepatol. 2025; 10: e10. 10.1016\/S2468-1253(25)00203-1","DOI":"10.1016\/S2468-1253(24)00034-7"},{"key":"10161_CR47","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s00535-025-02279-z","volume":"60","author":"S Akiyama","year":"2025","unstructured":"Akiyama S, Ito Y, Shiroyama M et al. Increasing age at diagnosis raises malignancy risk and aminosalicylate intolerance influences therapeutic strategies in ulcerative colitis: a multicenter I-BRITE cohort study. J Gastroenterol. 2025;60:1259\u20131271. https:\/\/doi.org\/10.1007\/s00535-025-02279-z.","journal-title":"J Gastroenterol."},{"key":"10161_CR48","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.dld.2024.02.002","volume":"56","author":"K Anisdahl","year":"2024","unstructured":"Anisdahl K, Lirhus SS, Medhus AW et al. Frailty risk and treatment strategy in elderly-onset inflammatory bowel disease. A Norwegian nationwide population-based registry study. Dig Liver Dis. 2024;56:1503\u20131510. https:\/\/doi.org\/10.1016\/j.dld.2024.02.002.","journal-title":"Dig Liver Dis."},{"key":"10161_CR49","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/ibd\/izac242","volume":"29","author":"Silvia Salvatori","year":"2023","unstructured":"Salvatori Silvia, Marafini Irene, Venuto Chiara et al. Frail Phenotype in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2023;29:1555\u20131562. https:\/\/doi.org\/10.1093\/ibd\/izac242.","journal-title":"Inflammatory Bowel Diseases"},{"key":"10161_CR50","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1056\/NEJMra2301292","volume":"391","author":"DH Kim","year":"2024","unstructured":"Kim DH, Rockwood K. Frailty in older adults. New England Journal of Medicine 2024;391:538\u2013548.","journal-title":"New England Journal of Medicine"},{"key":"10161_CR51","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1007\/s10620-025-09073-0","volume":"70","author":"J Bahirwani","year":"2025","unstructured":"Bahirwani J, Elmer J, Eskarous H et al. Frailty Prevalence and Evaluation of the FRAIL Scale Questionnaire in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2025;70:2815\u20132822. https:\/\/doi.org\/10.1007\/s10620-025-09073-0.","journal-title":"Dig Dis Sci."},{"key":"10161_CR52","doi-asserted-by":"publisher","unstructured":"Asscher VER, Waars SN, van der Meulen-de Jong AE et al. Deficits in Geriatric Assessment Associate With Disease Activity and Burden in Older Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2022; 20: e1006-e1021. https:\/\/doi.org\/10.1016\/j.cgh.2021.06.015. Erratum in: Clin Gastroenterol Hepatol. 2023; 21: 3466. 10.1016\/j.cgh.2023.08.018","DOI":"10.1016\/j.cgh.2021.06.015"},{"key":"10161_CR53","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1016\/j.cgh.2022.01.001","volume":"20","author":"B Kochar","year":"2022","unstructured":"Kochar B, Jylh\u00e4v\u00e4 J, S\u00f6derling J, SWIBREG Study Group et al. Prevalence and Implications of Frailty in Older Adults With Incident Inflammatory Bowel Diseases: A Nationwide Cohort Study. Clin Gastroenterol Hepatol. 2022;20:2358-2365.e11. https:\/\/doi.org\/10.1016\/j.cgh.2022.01.001.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10161_CR54","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1053\/j.gastro.2020.02.032","volume":"158","author":"B Kochar","year":"2020","unstructured":"Kochar B, Cai W, Cagan A, Ananthakrishnan AN. Pretreatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients With Inflammatory Bowel Diseases. Gastroenterology. 2020;158:2104-2111.e2. https:\/\/doi.org\/10.1053\/j.gastro.2020.02.032.","journal-title":"Gastroenterology."},{"key":"10161_CR55","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1093\/ecco-jcc\/jjad175","volume":"18","author":"VER Asscher","year":"2024","unstructured":"Asscher VER, Rodriguez G\u00edrondo M, Fens J et al. Frailty Screening is Associated with Hospitalization and Decline in Quality of Life and Functional Status in Older Patients with Inflammatory Bowel Disease. J Crohns Colitis. 2024;18:516\u2013524. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjad175.","journal-title":"J Crohns Colitis."},{"key":"10161_CR56","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.dld.2024.01.196","volume":"56","author":"AB Fons","year":"2024","unstructured":"Fons AB, Asscher VER, Stuyt RJL et al. Deficits in geriatric assessment are important in relation to fatigue in older patients with Inflammatory Bowel Disease. Dig Liver Dis. 2024;56:1490\u20131496. https:\/\/doi.org\/10.1016\/j.dld.2024.01.196.","journal-title":"Dig Liver Dis."},{"key":"10161_CR57","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/apt.15821","volume":"52","author":"B Kochar","year":"2020","unstructured":"Kochar B, Cai W, Cagan A, Ananthakrishnan AN. Frailty is independently associated with mortality in 11 001 patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2020;52:311\u2013318. https:\/\/doi.org\/10.1111\/apt.15821.","journal-title":"Aliment Pharmacol Ther."},{"key":"10161_CR58","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.cgh.2020.08.010","volume":"19","author":"AS Qian","year":"2021","unstructured":"Qian AS, Nguyen NH, Elia J et al. Frailty is independently associated with mortality and readmission in hospitalized patients with inflammatory bowel diseases. Clinical Gastroenterology and Hepatology 2021;19:2054\u20132063.","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10161_CR59","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8.","journal-title":"J Chronic Dis."},{"key":"10161_CR60","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/ibd\/izaa263","volume":"27","author":"G Chen","year":"2021","unstructured":"Chen G, Lissoos T, Dieyi C, Null KD. Development and Validation of an Inflammatory Bowel Disease Severity Index Using US Administrative Claims Data: A Retrospective Cohort Study. Inflamm Bowel Dis. 2021;27:1177\u20131183. https:\/\/doi.org\/10.1093\/ibd\/izaa263.","journal-title":"Inflamm Bowel Dis."},{"key":"10161_CR61","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-230X-12-79","volume":"26","author":"JL Sewell","year":"2012","unstructured":"Sewell JL, Yee HF Jr. 13-year mortality trends among hospitalized patients with inflammatory bowel disease. BMC Gastroenterol. 2012;26:79. https:\/\/doi.org\/10.1186\/1471-230X-12-79.","journal-title":"BMC Gastroenterol."},{"key":"10161_CR62","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/apt.16073","volume":"52","author":"VER Asscher","year":"2020","unstructured":"Asscher VER, Biemans VBC, Pierik MJ, Dutch Initiative on Crohn and Colitis (ICC) et al. Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort study. Aliment Pharmacol Ther. 2020;52:1366\u20131376. https:\/\/doi.org\/10.1111\/apt.16073.","journal-title":"Aliment Pharmacol Ther."},{"key":"10161_CR63","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1097\/MEG.0000000000001768","volume":"32","author":"W Chan","year":"2020","unstructured":"Chan W, Kariyawasam VC, Kim S et al. Gastroenterologists\u2019 preference and risk perception on the use of immunomodulators and biological therapies in elderly patients with ulcerative colitis: an international survey. Eur J Gastroenterol Hepatol. 2020;32:976\u2013983. https:\/\/doi.org\/10.1097\/MEG.0000000000001768.","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10161_CR64","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1111\/j.1532-5415.2005.53512.x","volume":"53","author":"SC Castle","year":"2005","unstructured":"Castle SC, Uyemura K, Rafi A, Akande O, Makinodan T. Comorbidity is a better predictor of impaired immunity than chronological age in older adults. J Am Geriatr Soc. 2005;53:1565\u20131569. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53512.x.","journal-title":"J Am Geriatr Soc."},{"key":"10161_CR65","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1097\/MIB.0000000000000391","volume":"21","author":"A Parian","year":"2015","unstructured":"Parian A, Ha CY. Older age and steroid use are associated with increasing polypharmacy and potential medication interactions among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:1392\u20131400. https:\/\/doi.org\/10.1097\/MIB.0000000000000391.","journal-title":"Inflamm Bowel Dis."},{"key":"10161_CR66","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.cgh.2006.09.019","volume":"4","author":"G Gupta","year":"2006","unstructured":"Gupta G, Lautenbach E, Lewis JD. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:1483\u20131490. https:\/\/doi.org\/10.1016\/j.cgh.2006.09.019.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10161_CR67","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cgh.2010.09.026","volume":"9","author":"Mario Cottone","year":"2011","unstructured":"Cottone Mario, Kohn Anna, Daperno Marco, Armuzzi Alessandro, Guidi Luisa, D\u2019Inca Renata, Bossa Fabrizio et al. Advanced age is an independent risk factor for severe infections and mortality in patients given anti\u2013tumor necrosis factor therapy for inflammatory bowel disease. Clinical Gastroenterology and Hepatology 2011;9:30\u201335.","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10161_CR68","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz065","author":"N Khan","year":"2020","unstructured":"Khan N, Vallarino C, Lissoos T, Darr U, Luo M. Risk of infection and types of infection among elderly patients with inflammatory bowel disease: a retrospective database analysis. Inflamm Bowel Dis. 2020. https:\/\/doi.org\/10.1093\/ibd\/izz065.","journal-title":"Inflamm Bowel Dis."},{"key":"10161_CR69","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/apt.15692","volume":"51","author":"D Piovani","year":"2020","unstructured":"Piovani D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, Bonovas S. Systematic review with meta-analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2020;51:820\u2013830. https:\/\/doi.org\/10.1111\/apt.15692.","journal-title":"Aliment Pharmacol Ther."},{"key":"10161_CR70","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.cgh.2018.12.032","volume":"17","author":"NZ Borren","year":"2019","unstructured":"Borren NZ, Ananthakrishnan AN. Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2019;17:1736-1743.e4. https:\/\/doi.org\/10.1016\/j.cgh.2018.12.032.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10161_CR71","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/ijc.33932","volume":"150","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zhang M, Chen X et al. Risk of malignancy in patients with inflammatory bowel disease: A population-based cohort study from China. Int J Cancer. 2022;150:1770\u20131778. https:\/\/doi.org\/10.1002\/ijc.33932.","journal-title":"Int J Cancer."},{"key":"10161_CR72","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s40266-017-0498-y","volume":"34","author":"N Khan","year":"2017","unstructured":"Khan N, Vallarino C, Lissoos T, Darr U, Luo M. Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients. Drugs Aging. 2017;34:859\u2013868. https:\/\/doi.org\/10.1007\/s40266-017-0498-y.","journal-title":"Drugs Aging."},{"key":"10161_CR73","doi-asserted-by":"publisher","unstructured":"Hsieh TJ, Su SC, Chen CW et al. Individualized home-based exercise and nutrition interventions improve frailty in older adults: a randomized controlled trial. Int J Behav Nutr Phys Act. 2019; 16(1):119. https:\/\/doi.org\/10.1186\/s12966-019-0855-9. Erratum in: Int J Behav Nutr Phys Act. 2019 23; 16(1):136. 10.1186\/s12966-019-0905-3","DOI":"10.1186\/s12966-019-0855-9"},{"key":"10161_CR74","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.amjmed.2015.06.017","volume":"128","author":"TP Ng","year":"2015","unstructured":"Ng TP, Feng L, Nyunt MS et al. Nutritional, Physical, Cognitive, and Combination Interventions and Frailty Reversal Among Older Adults: A Randomized Controlled Trial. Am J Med. 2015;128:1225-1236.e1. https:\/\/doi.org\/10.1016\/j.amjmed.2015.06.017.","journal-title":"Am J Med."},{"key":"10161_CR75","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/jamainternmed.2020.0618","volume":"180","author":"ST Nyberg","year":"2020","unstructured":"Nyberg ST, Singh-Manoux A, Pentti J et al. Association of Healthy Lifestyle With Years Lived Without Major Chronic Diseases. JAMA Intern Med. 2020;180:760\u2013768. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0618.","journal-title":"JAMA Intern Med."},{"key":"10161_CR76","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.amjmed.2023.12.028","volume":"137","author":"MJ Koren","year":"2024","unstructured":"Koren MJ, Kelly NA, Lau JD et al. Association of Healthy Lifestyle and Incident Polypharmacy. Am J Med. 2024;137:433-441.e2. https:\/\/doi.org\/10.1016\/j.amjmed.2023.12.028.","journal-title":"Am J Med."},{"key":"10161_CR77","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.14309\/ajg.0000000000003541","volume":"120","author":"FA Farraye","year":"2025","unstructured":"Farraye FA, Melmed GY, Lichtenstein GR et al. ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol. 2025;120:1447\u20131473. https:\/\/doi.org\/10.14309\/ajg.0000000000003541.","journal-title":"Am J Gastroenterol."},{"key":"10161_CR78","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.cgh.2024.12.011","volume":"23","author":"F Caldera","year":"2025","unstructured":"Caldera F, Kane S, Long M, Hashash JG. AGA Clinical Practice Update on Noncolorectal Cancer Screening and Vaccinations in Patients With Inflammatory Bowel Disease: Expert Review. Clin Gastroenterol Hepatol. 2025;23:695\u2013706. https:\/\/doi.org\/10.1016\/j.cgh.2024.12.011.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10161_CR79","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/apt.15214","volume":"49","author":"S Singh","year":"2019","unstructured":"Singh S, Stitt LW, Zou G et al. Early combined immunosuppression may be effective and safe in older patients with Crohn\u2019s disease: post hoc analysis of REACT. Aliment Pharmacol Ther. 2019;49:1188\u20131194. https:\/\/doi.org\/10.1111\/apt.15214.","journal-title":"Aliment Pharmacol Ther."},{"key":"10161_CR80","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/ibd\/izab074","volume":"28","author":"S Singh","year":"2022","unstructured":"Singh S, Qian AS, Nguyen NH et al. Trends in U.S. Health Care Spending on Inflammatory Bowel Diseases, 1996\u20132016. Inflamm Bowel Dis. 2022;28:364\u2013372. https:\/\/doi.org\/10.1093\/ibd\/izab074.","journal-title":"Inflamm Bowel Dis."},{"key":"10161_CR81","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/ecco-jcc\/jjaa181","volume":"15","author":"JWY Mak","year":"2021","unstructured":"Mak JWY, Lok Tung Ho C, Wong K et al. Epidemiology and Natural History of Elderly-onset Inflammatory Bowel Disease: Results From a Territory-wide Hong Kong IBD Registry. J Crohns Colitis. 2021;15:401\u2013408. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa181.","journal-title":"J Crohns Colitis."},{"key":"10161_CR82","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jval.2017.02.005","volume":"20","author":"Kyle D Null","year":"2017","unstructured":"Null Kyle D, Yihua Xu, Pasquale Margaret K et al. Ulcerative Colitis Treatment Patterns and Cost of Care. Value in Health 2017;20:752\u2013761. https:\/\/doi.org\/10.1016\/j.jval.2017.02.005.","journal-title":"Value in Health"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10161-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10161-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10161-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:06:37Z","timestamp":1789625197000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10161-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,9]]},"references-count":82,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10161"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10161-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,9]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}